Correction to: Selective kappa-opioid antagonism ameliorates anhedonic behavior: evidence from the Fast-fail Trial in Mood and Anxiety Spectrum Disorders (FAST-MAS)
Neuropsychopharmacology
.
2021 Nov;46(12):2224.
doi: 10.1038/s41386-021-01145-9.
Authors
Diego A Pizzagalli
1
,
Moria Smoski
2
,
Yuen-Siang Ang
3
,
Alexis E Whitton
4
,
Gerard Sanacora
5
,
Sanjay J Mathew
6
7
,
John Nurnberger Jr
8
,
Sarah H Lisanby
9
,
Dan V Iosifescu
10
,
James W Murrough
11
,
Hongqiu Yang
12
,
Richard D Weiner
2
,
Joseph R Calabrese
13
,
Wayne Goodman
6
,
William Z Potter
9
,
Andrew D Krystal
2
14
Affiliations
1
McLean Hospital, Harvard Medical School, Belmont, MA, USA. dap@mclean.harvard.edu.
2
Duke University School of Medicine, Durham, NC, USA.
3
McLean Hospital, Harvard Medical School, Belmont, MA, USA.
4
School of Medical Sciences, The University of Sydney, Sydney, NSW, Australia.
5
Yale University School of Medicine, New Haven, CT, USA.
6
Baylor College of Medicine, Houston, TX, USA.
7
Michael E. Debakey VA Medical Center, Houston, TX, USA.
8
Indiana University School of Medicine, Indianapolis, IN, USA.
9
National Institute of Mental Health, Bethesda, MD, USA.
10
New York University School of Medicine, New York, NY, USA.
11
Icahn School of Medicine at Mount Sinai, New York, NY, USA.
12
Duke Clinical Research Institute, Durham, NC, USA.
13
Case Western Reserve School of Medicine, Cleveland, OH, USA.
14
University of California San Francisco, San Francisco, CA, USA.
PMID:
34389811
PMCID:
PMC8505431
DOI:
10.1038/s41386-021-01145-9
No abstract available
Publication types
Published Erratum
Grants and funding
UL1 TR001863/TR/NCATS NIH HHS/United States